I think that Daisuke Shishikura is a researcher at SAHMRI (South Australian Health and Medical Research Institute) in Adelaide, Australia and a part of Stephen Nicholls group there. You can read more about Stephen Nicholls bio here. Nicholls was a lead investigator on the ASSURE trial while at Cleveland Clinic. Nicholls is professor at SAHMRI now, but Nicholls is still a senior consultant to Cleveland Clinic. This abstract with  Daisuke Shishikura entitled "The effect of apabetalone on attenuated coronary atherosclerotic plaque: insights from the ASSURE trial" looks to be a follow up analysis of the ASSURE intravascular ultrasound (IVUS) data. Perhaps a chance for Cleveland Clinic/SAHMRI to officially present/comment on some of the subgroup/post-hoc analyses from ASSURE?

BDAZ